Intervention not reported
Adverse events Participants (n) reported adverse effects · patients with treating osteoarthritis
The intervention showed no clear difference in adverse events Participants (n) reported adverse effects (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events: a. mild hypoglycaemia (% of participants)
1 finding from 1 review
Adverse events: Clinically important specific adverse events · People with serious mental illness (all included participants had schizophrenia); majority aged 18 to 65 years per NIMH 1987, or with…
The review found no eligible studies for this question.
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) withdrew due to adverse effects · patients with treating osteoarthritis
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) withdrew due to adverse effects · patients with treating osteoarthritis
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) withdrew due to adverse effects · patients with treating osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · patients with treating osteoarthritis
It is very uncertain whether boswellia serrata changes adverse events Participants (n) withdrew due to adverse effects compared with valdecoxib (very low certainty).
1 finding from 1 review
Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) withdrew due to adverse effects · patients with osteoarthritis
The intervention showed no clear difference in adverse events Participants (n) withdrew due to adverse effects (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) withdrew due to adverse effects · patients with treating osteoarthritis
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with osteoarthritis
The intervention showed no clear difference in adverse events Participants (n) reported serious adverse events (moderate certainty).
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) withdrew due to adverse effects · patients with osteoarthritis
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with osteoarthritis
1 finding from 1 review
Intervention not reported
Adverse events Participants (n) reported serious adverse events · patients with treating osteoarthritis
The review found no eligible studies for this question.
1 finding from 1 review
no estimate extracted
Studies not reported
No studies found
Withdrawals due to adverse events · patients with osteoarthritis
1 finding from 1 review
Adverse events Participants (n) reported serious adverse events · patients with osteoarthritis
Persea gratissma + Glycine max (ASU 300 mg) showed no clear difference in adverse events Participants (n) reported serious adverse events compared with chondroitin sulphate (low certainty).
1 finding from 1 review
Intervention not reported
Adverse events: a. mild hypoglycaemia (episodes per participant)
1 finding from 1 review